“Gene therapy for hemophilia A with the use of lentiviral vector-transduced autologous HSCs resulted in stable factor VIII expression, with factor VIII activity correlating to vector copy number in ...
Am J Health Syst Pharm. 2006;63(17):1641-1646. Our institution, the University of Virginia Health System (UVHS), added factor VIIa (recombinant) to its formulary on August 27, 1999. Informal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback